CapWealth Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,171
Closed -$223K 101
2020
Q1
$223K Buy
9,171
+942
+11% +$23.7K 0.04% 83
2019
Q4
$230K Buy
+8,229
New +$213K 0.03% 95
2019
Q3
Sell
-8,121
Closed -$232K 104
2019
Q2
$232K Buy
+8,121
New +$203K 0.03% 90

Other funds holding VCYT

CapWealth Advisors's VCYT Position: Q2 2020 in Review

CapWealth Advisors sold out of Veracyte (VCYT) in Q2 2020, closing a stake of 9,171 shares — an estimated $223K sold.

CapWealth Advisors first reported a position in VCYT in Q2 2019 and held it in 3 quarters. The position peaked at $232K in Q2 2019. 166 funds tracked by Wall St. Rank hold VCYT as of Q2 2020.

  • CapWealth Advisors reported no remaining Veracyte position as of Q2 2020 after selling out during the quarter.
  • CapWealth Advisors sold 9,171 Veracyte shares in Q2 2020, an estimated $223K.
  • CapWealth Advisors first reported a position in Veracyte in Q2 2019 and held it in 3 quarters.
  • CapWealth Advisors's Veracyte position peaked at $232K in Q2 2019.
  • 166 funds tracked by Wall St. Rank held Veracyte as of Q2 2020.

Based on CapWealth Advisors's 13F filing for Q2 2020, filed 12 Aug 2020.